NAD+ — lot not stated — Lab 200516

← All lot records
Lot record

NAD+ — lot not stated — Lab 200516

A vial from this lot was sent to Krause Analytical for independent analysis. This page is the record of what came back, published whole and unedited.
Released 100 mg vial Lab No. 200516
Laboratory
Krause Analytical
Sample received
29 January 2026
Results reported
2 March 2026
BATCH
VERIFICATION
LOT NUMBER
100 mg vial
IDENTITY
Confirmed
CHROMATOGRAPHIC PURITY
99.89 %
NET CONTENT
82.5 mg
criterion: at or above label claim
Analytical characterization

Every result against its specification.

Lot · 100 mg vial · Krause Analytical · reported 2 March 2026 . The bar shows where the reported result falls against Astramide’s published release criterion. The notch marks the criterion.
Within criterion Below label claim Above criterion Failed Not on this COA
Test
Method
Criterion
Result
Result vs criterion
Status
Identity
HPLC-UV-MS
Mass spectral match to the labelled compound
Confirmed
WITHIN SPEC
Chromatographic purity
HPLC-UV/MS
at or above 98.0%
99.89 %
95 at or above 98.0% 100
WITHIN SPEC
Net content
HPLC-UV-MS
at or above label claim
82.5 mg
80 at or above label claim 120
UNDER LABEL
Endotoxin
LAL, USP <85>
below 0.5 EU/mL
<0.5 EU/mL
WITHIN SPEC
Values are reported per vial unless otherwise noted. Every figure here is taken from the batch Certificate of Analysis and nothing else.
Certificate of Analysis
NAD+ — lot not stated — Lab 200516
Download Full screen
Your browser cannot display the report inline. Open the PDF.
Krause Analytical · 1 page · served inline, not a screenshot
Quick reference

How to read this report

Same six keys on every Astramide product page. Only the values change.
1Lot numberMatch it to the number printed on your vial. If they differ, this report is not for your vial.
2IdentityMass spectrometry confirms the molecule is the one on the label. It conforms or it does not. There is no partial result.
3Chromatographic purityThe share of the material that is the target peptide. A purity figure quoted without a method is not a purity figure.
4Net content, and percent of labelHow much peptide is in the vial against what the label claims. A different question from purity. High purity with low content means clean material in an under-filled vial.
5EndotoxinMeasured against a ceiling, not a floor. Sensitivity differs by laboratory, so results are not compared across labs.
6Laboratory, method, dateWho ran it, on what instrument, and when. A report with no named laboratory or no date is not a report.

What does this record cover?

One lot, and one lot only: lot , in the 100 mg vial. Results from one lot do not carry over to the next. Match the lot number printed on your vial to the lot number on this page before you rely on any figure here. If the two differ, this is not the report for your vial.

Who ran the testing?

Krause Analytical ran the analysis. Astramide does not test its own material and does not report its own numbers. How we test sets out which laboratories we use and what each method measures.

Where is the original document?

The Certificate of Analysis above is the laboratory’s own PDF, served whole and downloadable. It is not a screenshot, a transcription or a summary. Every figure on this page is read from it. Every lot we have tested is published the same way, including the ones we rejected.

Research use only

All products sold by Astramide are intended exclusively for laboratory research purposes. They are not intended for human consumption, medical, therapeutic, or diagnostic use.